Loading data...
Edgewater Inc.
CEO
Masahiko Fukuzawa
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
Based on research from RIKEN on "predicting immune status," we have developed the world's first "Immune Management" system that utilizes AI analysis to evaluate an individual's innate immune foundation. Our system detects early signs of serious immune-related adverse events (irAEs) in cancer immunotherapy, thereby preventing treatment interruption. Our world-first system, which integrates with electronic medical records (EMR) to automatically alert physicians and provide intervention protocols, is protected by proprietary patents. We exclusively operate a business that maximizes pharmaceutical companies' revenues while providing the world's first longitudinal immune RWD (Real-World Data).
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
AI / データ活用, Healthcare / Biotech
本社所在地
Chiyoda-ku, Tokyo, Japan
設立日
2015年1月15日
資本金
null
Employee Count
3
Industry Outlook & Trends for Edgewater Inc.
In the AI and data analytics market where Edgewater Inc. is active, the industry is shifting from proof-of-concept to real business integration. Demand is surging for systems that securely connect proprietary corporate data with AI to automate advanced analysis. In addition to text generation, multimodal AI and autonomous AI agents are accelerating. The key source of competitiveness now lies in maximizing data value, driving growth for innovative leaders like Edgewater Inc..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.